1Shevde N K, Bendixen A C, Dienger K M, et al. Estrogens suppress RANK ligand -induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression[J]. Proc Natl Sci USA, 2000,14:7829-7834.
2Parfitt A M, Mundy G R, Roodman G D, et al. A new model for the regulation of bone resorption , with particular reference to the effects of bisphosphonates [J]. J Bone Miner Res, 1996,11:150-159.
3Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis [J]. J Bone Miner Res, 1996, 11:1043-1051.
4Shevde N K, Pike J W. Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cellindependent mechanism involving apoptosis [ J ]. Blood,1996,87: 2683-2692.
5Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function[J]. Biochem Biophys Res Commun, 1999,256:449-455.
6Rogers A,Eastell R.Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood[J].J Bone Miner Res,1998,13:1577-1586.
7Maruo N,Chen J T,Ogata E,et al.Serum levels of soluble interleukin 6 receptor is correlated with the change of bone metabolism during estrogen therapy[J].Bone Miner Res,1996,11:sll8(abstract).
8Abrahamsen B,Bonnevie-Nielsen V,Ebbesen E N,et al.Cytokines and bone loss in a 5-year longitudinal study-hor-mone replacementtherapy suppresses serum soluble interleu-kin-6 receptor and increases interleukin-l-receptor antagonist:The Danish osteoporosis prevention study[J].J Bone Miner Res,2000,15:1545-1552.
9Kimble R B,Bain S,Pacifici R.The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice[J] J Bone Miner Res,1997,12:935-941.
10Lorenzo J.Interactions between immune and bone cells:new insights with many remaining questions[J].J Clin Invest,2000,106:749-752.
